Your browser doesn't support javascript.
loading
A good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year.
Carter, John-Paul; Foard, Darren; Rannigan, Lisa; Aliaz, Kamela; Mahmood, Shameem; Sachchithanantham, Sajitha; Fontana, Marianna; Quarta, Cristina; Martinez De Azcona Naharro, Ana; Youngstein, Taryn; Rezk, Tamer; Wechalekar, Ashutosh; Whelan, Carol; Lachmann, Helen; Hawkins, Philip; Gillmore, Julian; Lane, Thirusha.
  • Carter JP; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Foard D; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Rannigan L; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Aliaz K; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Mahmood S; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Sachchithanantham S; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Fontana M; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Quarta C; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Martinez De Azcona Naharro A; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Youngstein T; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Rezk T; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Wechalekar A; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Whelan C; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Lachmann H; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Hawkins P; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Gillmore J; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
  • Lane T; a National Amyloidosis Centre, Division of Medicine, Royal Free Campus, University College London , UK.
Amyloid ; 24(sup1): 72-73, 2017 03.
Article en En | MEDLINE | ID: mdl-28434320
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Antineoplásicos Alquilantes / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Melfalán Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Antineoplásicos Alquilantes / Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas / Melfalán Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article